WEDNESDAY, Feb. 17, 2021 (HealthDay Information) — Lower than half of physicians ask allergy and bronchial asthma sufferers about hashish use, in response to a examine revealed on-line Jan. 16 within the Annals of Allergy, Bronchial asthma and Immunology.
Joanna S. Zeiger, Ph.D., from the Canna Analysis Basis in Boulder, Colorado, and colleagues carried out a survey to determine patterns of use and attitudes towards hashish in 489 grownup allergy and bronchial asthma sufferers.
The researchers discovered that 18 p.c of respondents presently use hashish, with the bulk being youthful than 50 years outdated, feminine, and White. Amongst respondents who reported not utilizing hashish, 2.5 p.c reported hashish allergy. 4 in 10 present hashish customers (40.9 p.c) reported a doctor inquiring about hashish use, however solely 37.5 p.c of respondents needed to debate hashish. Practically two-thirds (65.9 p.c) reported utilizing hashish for medical or medical/leisure functions. Smoked hashish was reported by 53.4 p.c versus 35.2 p.c who reported vaped hashish. Amongst hashish customers, 58 p.c reported present bronchial asthma, with 39.2 p.c saying it’s uncontrolled. Considerably extra sufferers reported optimistic hashish results than detrimental results.
“With the intention to extra utterly handle their allergy/bronchial asthma sufferers, allergists ought to enhance their information about hashish and inquire about hashish use together with sorts of cannabinoid, route of use, causes to be used, and hostile results,” a coauthor stated in a press release.
One creator disclosed monetary ties to the pharmaceutical business.